Suchergebnisse - "Zambelli, Alberto"

PubPharm (171)

71

Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer : learning from the past to design future strategies

enthalten in: Expert opinion on therapeutic targets | 2020

von Pegoraro, S. | Ros, G. | Sgubin, M. | +4

72

Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy : The BONDX study

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Zambelli, A. | Simoncini, E. | Giordano, M. | +11

73

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients

enthalten in: Cancer discovery | 2020

von Pinato, D. | Zambelli, A. | Aguilar-Company, J. | +61

74

Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?

enthalten in: ESMO open | 2020

von Zambelli, A. | Tondini, C.

CommentOn: Ann Oncol. 2019 Oct 1;30(10):1674. - PMID 31236598

75

Adding pertuzumab to adjuvant therapy for high-risk HER2-positive early breast cancer in APHINITY : a GRADE analysis

enthalten in: Journal of comparative effectiveness research | 2020

von Zambelli, A. | Pappagallo, G. | Marchetti, P.

76

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting : The EVA and GIM-13 AMBRA Studies

enthalten in: Breast care (Basel, Switzerland) | 2020

von Cazzaniga, M. | Verusio, C. | Ciccarese, M. | +48

77

International electronic health record-derived COVID-19 clinical course profiles : the 4CE consortium

enthalten in: NPJ digital medicine | 2020

von Brat, G. | Weber, G. | Gehlenborg, N. | +84

78

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients : Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)

enthalten in: Cancers | 2019

von Dieci, M. | Del Mastro, L. | Cinquini, M. | +14

79

Correction 2 : Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

enthalten in: Oncotarget | 2018

von Cazzaniga, M. | Verusio, C. | Ciccarese, M. | +35

ErratumFor: Oncotarget. 2018 Aug 7;9(61):31877-31887. - PMID 30159129

80

T-DM1 and brain metastases : Clinical outcome in HER2-positive metastatic breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2018

von Fabi, A. | Alesini, D. | Valle, E. | +27